Sanofi’s Keeney On Early-Stage Assets, 'Open Dialogue' With Asian Start-Ups
Executive Summary
Dr. Adam Keeney, Global Head, External Innovation and R&D Strategy at Sanofi, outlines in an interview with Scrip the company’s interest in early-stage assets and intent to tap into opportunities in Asia-Pacific. He also discusses the region’s role as a digital hub.